This contract involves the execution and reporting of genomic profiling tests specifically for patients diagnosed with early-stage invasive luminal HER2-negative breast cancer. The aim is to provide accurate genomic data that can assist in the treatment planning and management of these patients. The
Contract awarded. Originally published 1 years ago.
Only 2 prior awards here — too little to read.
In healthcare medical, ORG0001 has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract opportunity involves the supply of analytical systems for serological diagnostics. The public sector is seeking suppliers who can provide high-quality diagnostic equipment that meets health sector standards. The total value of the contract is approximately €54,651,618.40. Interested su
This contract opportunity is for insurance services required from 2024 to 2030. The total value of the contract is approximately €1,197,084.78. Suppliers are invited to participate in an open procedure to provide these financial and insurance services. For more details, please visit the contract pla
This contract opportunity involves the construction work for Phase B of the Genoa Outer Dam project in Italy. The total value of the contract is approximately €444 million. Suppliers are invited to submit their bids for this significant construction project, which aims to enhance coastal protection
This contract opportunity is for Phase 2 of the architectural services project in Italy. The total value of the contract is approximately €17,763,548.85. Suppliers are invited to provide architectural and related services, which may include design, planning, and project management. The deadline for
Opportunity to become a pathology testing services provider through a Provider Selection Regime process.
Seeking qualified providers to deliver pathology testing services through a Provider Selection Regime process.
Bristol NHS Foundation Trust is procuring a managed service provider to deliver comprehensive lung cancer screening services across the SWAG region from April 2027 for up to 60 months.
NHSBT seeks gamma irradiation service providers for tissue allografts and medical consumables with specific dose specifications, rapid turnaround, and quality management capabilities.
